SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-009348
Filing Date
2023-03-28
Accepted
2023-03-28 20:05:09
Documents
1
Period of Report
2023-03-24

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3733
  Complete submission text file 0001493152-23-009348.txt   5191
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Issuer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VIRPAX PHARMACEUTICALS, INC. 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address
Ruskin Barbara (Reporting) CIK: 0001969041 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40064 | Film No.: 23771424